Dr Nicholas Boyd is the Chief Development Officer at Cartherics PL, a biotech specializing in novel ‘off-the-shelf’, on-demand, stem cell-derived immunotherapies. With his PhD in nanomaterials and bioengineering, Nicholas has specialized in interfacing stem cells with immune effectors, culminating in the proprietary development of genetically-edited natural killer cells from induced pluripotential stem cells. His core focus is now their scale-up manufacture and clinical translation.